Idogen Financial Statements From 2010 to 2024
| IDOGEN Stock | SEK 0.12 0.00 0.00% |
Check Idogen AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Idogen AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Idogen financial statements analysis is a perfect complement when working with Idogen AB Valuation or Volatility modules.
Idogen |
Idogen AB Company Operating Margin Analysis
Idogen AB's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Idogen AB Operating Margin | (14.24) % |
Most of Idogen AB's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Idogen AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Idogen AB has an Operating Margin of -14.2427%. This is much lower than that of the sector and significantly lower than that of the Biotechnology industry. The operating margin for all Sweden stocks is notably higher than that of the company.
Idogen AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Idogen AB's current stock value. Our valuation model uses many indicators to compare Idogen AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Idogen AB competition to find correlations between indicators driving Idogen AB's intrinsic value. More Info.Idogen AB is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Idogen AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Idogen AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Idogen AB Financial Statements
Idogen AB stakeholders use historical fundamental indicators, such as Idogen AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although Idogen AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in Idogen AB's assets and liabilities are reflected in the revenues and expenses on Idogen AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Idogen AB. Please read more on our technical analysis and fundamental analysis pages.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Idogen Stock
Idogen AB financial ratios help investors to determine whether Idogen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Idogen with respect to the benefits of owning Idogen AB security.